Imunon (IMNN) Operating Income (2010 - 2026)
Imunon's (IMNN) quarterly Operating Income came in at -$4.3 million in Q1 2026, down 3.89% YoY from -$4.5 million in Q1 2025, and down 1.05% on a QoQ basis from -$4.3 million in Q4 2025.
Imunon (IMNN) Operating Income (2010 - 2026) Analysis & Trends
Imunon (IMNN) has 17 years of Operating Income data on file, last reported at -$4.3 million in Q1 2026.
- Quarterly Operating Income fell 3.89% year-over-year to -$4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.8 million (up 18.91% YoY) and the FY2025 annual result came in at -$14.7 million, up 23.42% from the prior year.
- Operating Income retreated to -$4.3 million in Q1 2026, from -$4.3 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$2.8 million in Q2 2025 to a low of -$6.9 million in Q4 2022.
- A 5-year average of -$4.9 million and a median of -$5.0 million in 2024 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income sank 143.79% — and 2025, when it jumped 44.79%.
- Tracing IMNN's Operating Income over 5 years: stood at -$6.9 million in 2022, then advanced by 13.85% to -$6.0 million in 2023, then jumped by 30.52% to -$4.1 million in 2024, then fell by 2.79% to -$4.3 million in 2025, then dropped by 1.05% to -$4.3 million in 2026.
- The last three Operating Income figures came in at -$4.3 million (Q1 2026), -$4.3 million (Q4 2025), and -$3.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | Imunon | 8.16 Mn | 8.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.31 Mn |
| Dec 31, 2025 | -4.26 Mn |
| Sep 30, 2025 | -3.48 Mn |
| Jun 30, 2025 | -2.77 Mn |
| Mar 31, 2025 | -4.15 Mn |
| Dec 31, 2024 | -4.15 Mn |
| Sep 30, 2024 | -4.96 Mn |
| Jun 30, 2024 | -5.01 Mn |
| Mar 31, 2024 | -5.01 Mn |
| Dec 31, 2023 | -5.97 Mn |
| Sep 30, 2023 | -3.90 Mn |
| Jun 30, 2023 | -5.47 Mn |
| Mar 31, 2023 | -5.68 Mn |
| Dec 31, 2022 | -6.93 Mn |
| Sep 30, 2022 | -6.17 Mn |
| Jun 30, 2022 | -5.98 Mn |
| Mar 31, 2022 | -5.84 Mn |
| Dec 31, 2021 | 15.82 Mn |
| Sep 30, 2021 | -5.06 Mn |
| Jun 30, 2021 | -5.07 Mn |